Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug;9(8):e80-e81.
doi: 10.1016/S2213-2600(21)00262-9. Epub 2021 Jun 16.

Extracorporeal membrane oxygenation for COVID-19 during first and second waves

Lars Mikael Broman  1 , Staffan Eksborg  2 , Valeria Lo Coco  3 , Maria Elena De Piero  4 , Jan Belohlavek  5 , Roberto Lorusso  6 ; EuroECMO COVID-19 Working Group; Euro-ELSO Steering Committee
Affiliations

Extracorporeal membrane oxygenation for COVID-19 during first and second waves

Lars Mikael Broman et al. Lancet Respir Med. 2021 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Members of the collaborator groups are listed in the appendix (pp 1–12). LMB is an advisor for Eurosets and Xenios. RL is a consultant for Medtronic, Getinge, LivaNova, and Abiomed; and an advisor for Eurosets. All other authors declare no competing interests. We thank Peter Radell (Karolinska University Hospital, Stockholm, Sweden) for editing the English language.

Figures

Figure 1
Figure 1
Cumulative outcome of ECMO for COVID-19 ECMO support from March 12, 2020, to March 8, 2021. First wave, defined from disease onset to Sept 14, 2020. Second wave defined from Sept 15, 2020, to March 8, 2021. ECMO=extracorporeal membrane oxygenation.
Figure 2
Figure 2
Relationship between survivors and patients deceased from COVID-19 supported with ECMO Median–median linear regression (dashed line). First wave defined from disease onset to Sept 14, 2020. Second wave defined from Sept 15, 2020, to March 8, 2021. ECMO=extracorporeal membrane oxygenation.
See this image and copyright information in PMC

References

    1. Lorusso R, Combes A, Coco VL, De Piero ME, Belohlavek J. ECMO for COVID-19 patients in Europe and Israel. Intensive Care Med. 2021;47:344–348. - PMC - PubMed
    1. RECOVERY Collaborative Group. Horby P, Lim WS, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384:693–704. - PMC - PubMed
    1. Tomazini BM, Maia IS, Cavalcanti AB, et al. Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial. JAMA. 2020;324:1307–1316. - PMC - PubMed
    1. Contou D, Fraissé M, Pajot O, Tirolien JA, Mentec H, Plantefève G. Comparison between first and second wave among critically ill COVID-19 patients admitted to a French ICU: no prognostic improvement during the second wave? Crit Care. 2021;25:3. - PMC - PubMed
    1. Barbaro RP, MacLaren G, Boonstra PS, et al. Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the extracorporeal life support organization registry. Lancet. 2020;396:1071–1078. - PMC - PubMed

MeSH terms